Benzinga's Microcap Movers for Tuesday September 4, 2012

Below are highlights from Benzinga's daily coverage of small cap and microcap securities making big moves:

Shares of NTS Realty Holdings

, the Louisville, KY developer of multifamily, and commercial and retail real estate properties, rose 53.16% Tuesday on 43 times average volume. NTS Realty Holdings Limited Partnership announced Friday that the board of directors of its managing general partner, NTS Realty Capital, Inc., received a non-binding proposal from NTS' founder and Chairman, Mr. J.D. Nichols and Mr. Brian F. Lavin, its Chief Executive Officer, for a going private transaction. The proposal contemplates the acquisition of all of the public limited partnership interests of the Company not already beneficially owned by Messrs. Nichols and Lavin at a price of $5.25 per share in cash. The proposed transaction will not result in a change of control with respect to the Company's existing debt arrangements. NTS Realty Holdings closed at $4.70 on Tuesday.

Shares of Lentuo International

, the China-based seller of new automobiles, auto parts, and accessories, rose 24.69% Tuesday on 6 times average volume. Lentuo International released the following statement on Tuesday: "In view of the unusual market activity in the company's stock, the New York Stock Exchange has contacted the company in accordance with its usual practice. The Company stated that its policy is not to comment on unusual market activity." Lentuo International closed at $2.02 on Tuesday.

Chelsea Therapeutics

, the Charlotte, NC development-stage pharmaceutical company, rose 19.05% Tuesday on 1.7 times average volume. Chelsea Therapeutics announced Tuesday it will present at the 14th Annual Rodman & Renshaw Global Healthcare Investment Conference at 3:40pm ET on Monday, September 10, 2012 at the Waldorf Astoria in New York City. Joseph G. Oliveto, Chelsea's Interim Chief Executive Officer will provide a corporate update and an overview of the Northera (droxidopa) development program. Chelsea Therapeutics closed at $1.25 on Tuesday.